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artery plaques in older persons, NutrAbstract Background and Aim: Previous studies have shown that increased levels of C-reac-
tive protein (CRP) predict cardiovascular events, including stroke, myocardial infarction and
death from cardiovascular causes. Previous studies have also shown that increased levels of
CRP are strong predictors of the progression of pre-existing carotid artery plaques. However,
whether CRP is involved in the development of new plaques, that may or may not be associated
with clinical events, in subjects with clean carotid arteries has been scarcely investigated.
Methods and Results: 486 ‘‘InCHIANTI’’ Study participants (200 men and 286 women, 72% aged
65 years and over) free from carotid artery plaques at baseline, also underwent carotid artery
scan three years later. We tested the association of baseline characteristics, cardiovascular
risk factors and inflammatory markers with the development of new carotid artery plaques.
Older participants were significantly more likely to develop new plaques. Independent of
age, the relative risks of developing new plaques associated with heavy smoking and family
history of atherosclerosis were 1.7 (95%CI 1.5e1.9) and 1.9 (95%CI 1.2e3.1), respectively.ovascular Rehabilitation, Don Gnocchi Foundation, Via Imprunetana 124, 50020 Pozzolatico,
4; fax: þ39 055 2601 256.
cchi.it, raffmoli@tin.it (R. Molino-Lova).
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artery plaques in older persons, NutParticipants with high (>3 mg/mL) and moderate (1 and 3 mg/mL) CRP levels had a relative
risk of 2.2 (95%CI 1.9e2.6) and 1.9 (95%CI 1.6e2.3) respectively, when compared with subjects
with low (<1 mg/mL) CRP levels. Surprisingly, risk factors such as hypertension, diabetes, dys-
lipidemia and overweight/obesity were not significant predictors of the development of new
carotid artery plaques.
Conclusions: High CRP levels independently predict the development of new plaques in older
persons with carotid arteries free from atherosclerotic lesions.
ª 2010 Elsevier B.V. All rights reserved.Introduction
In the last decade several prospective studies have shown
that C-reactive protein (CRP) is an independent predictor
of cardiovascular events, including stroke, myocardial
infarction and death from cardiovascular causes [1e5].
Though the prospective association of CRP with stroke is
robust [5], whether CRP predicts the development of new
plaques in subjects with clean carotid arteries has not yet
been completely clarified. In fact, the longitudinal studies
that consistently reported independent associations of CRP
with carotid atherosclerosis [6e12] mainly addressed the
progression of pre-existing plaques rather than the devel-
opment of new ones.
Interestingly, studies that used the Intima Media Thick-
ness (IMT) as an early measure of carotid atherosclerosis
consistently reported no independent association of CRP
with IMT [11,13e17], suggesting that IMT is scarcely
affected by inflammation [17e20].
Pre-clinical research [21e23] has proposed several
potential mechanisms for the initiation, the progression
and the thrombotic complications of atherosclerosis.
Though the link between risk factors and inflammation has
not yet been completely clarified, there is agreement that
inflammation might represent the final common pathway
that transduces the effects of risk factors into changes
within the vascular wall [23e25]. The effects of risk factors
on IMT [17e20], as well as those of inflammation on the
occurrence of cardiovascular events [1e5] and on the
progression of pre-existing carotid artery plaques [6e12],
have already been clarified. However, our understanding of
carotid atherosclerosis still shows a gap concerning factors
affecting the development of new plaques, that may or
may not be associated with clinical events, in subjects with
carotid arteries free from atherosclerotic lesions.
In this study we hypothesized that CRP might also be
a predictor of the development of new carotid artery pla-
ques. We tested this hypothesis using prospective data from
a population-based cohort of predominantly older persons,
who represent the portion of the population most likely to
develop carotid artery plaques.
Methods
Study sample
The analysis presented in this paper is based upon data
from the ‘‘InCHIANTI’’ (Invecchiare nel Chianti, Aging in
the Chianti area) Study, a prospective cohort investigation
on factors affecting loss of mobility in late life, whoseolino-Lova R, et al., High sensit
r Metab Cardiovasc Dis (2010), dodescription is reported on the web (www.inchiantistudy.
net) and in Ferrucci et al. [26].
Baseline data collection started in September 1998 and
was completed in March 2000. Of the 1453 interviewed
participants, 1168 (523 men and 645 women, mean age
68years  SD 15.4, 78% aged 65 and over) had complete
baseline data. During the three-year follow-up, 68 of the
1168 participants (37 men and 31 women, mean age at
baseline 82years  SD 7.6, 97% aged 65 and over, 48 with
and 20 without carotid artery plaques at baseline) died: of
these, 31 deaths were attributable to cardiovascular cau-
ses. Of the surviving 1100 participants, 261 (109 men and
152 women, mean age at baseline 74years  SD 14.6, 86%
aged 65 and over, 137 with and 124 without carotid artery
plaques at baseline) did not receive the follow-up scan due
to refusal or logistic difficulties in moving from home to the
ultrasound laboratory, while 839 participants (385 men and
454 women, mean age at baseline 66years  SD 15.1, 74%
aged 65 and over, 353 with and 486 without carotid artery
plaques at baseline) underwent the scheduled carotid
artery scan at three-year follow-up.
Consequently, the association of baseline characteris-
tics, risk factors and inflammatory markers with the
development of new carotid artery plaques at three-year
follow-up was assessed in the subgroup of 486 participants
(200 men and 286 women, mean age at baseline
60years  SD 16.6, 72% aged 65 and over) free from carotid
artery plaques at baseline.Carotid artery plaques
Carotid examination was performed both at baseline and at
three-year follow-up by the same expert operator using an
AU3 Partner apparatus (ESAOTE, Genoa, Italy) equipped
with a 7.5 MHz linear array transducer.
For our on-line analysis we adopted the protocol sug-
gested by Bots et al. [27] for the off-line analysis of carotid
artery scans in the Rotterdam Study, that was, to our
knowledge, the best available and the most updated one at
the time of the beginning of the InCHIANTI Study (1998). The
protocol included bilateral longitudinal and cross-sectional
scans of the distal part (2 cm) of the common carotid
artery, of the carotid bulb and of the proximal part (1 cm) of
external and internal carotid arteries. Plaques were defined
as ‘‘a focal widening relative to adjacent segments, with
protrusion into the lumen’’ judged visually, independent of
their extension and/or degree of stenosis [27]. Participants
with at least one plaque in one or both carotid arteries were
classed as ‘‘presence’’, and, conversely, participants with
both carotid arteries free from plaques were classed asivity C-reactive protein predicts the development of new carotid
i:10.1016/j.numecd.2010.02.003
ARTICLE IN PRESS
Inflammation and carotid artery plaques 3
+ MODEL‘‘absence’’. Based upon echographic pattern, each plaque
was also classed as hyper-reflecting, hypo-reflecting or
mixed [28].
High sensitivity CRP and other inflammatory
markers
Morning, fasting blood samples were collected after a 15-
min resting. Aliquots of serum were stored at 80C and
never thawed before analysis. Determination of CRP level
was based on a high sensitivity enzyme-linked immunosor-
bent assay (ELISA), using purified protein and polyclonal
anti-CRP antibodies [29]. The minimum detectable
concentration was 0.03 mg/mL. The average of two
measures performed on each sample was used in the
analysis. Serum IL-6, soluble IL-6 receptors (sIL-6r, 80 kDa),
IL-1beta, IL-1 receptor antagonist (IL-1ra) and TNF-a (kits
from BIOSOURCE, Camarillo, California) were also
measured in duplicate by high sensitivity enzyme-linked
immuno-absorbent assays [29].
Other variables
Family history of atherosclerosis was ascertained based
upon the report of death or morbidity for angina, myocar-
dial infarction or stroke in one or both parents, or in one or
more siblings, at the age under 65 years. Self-reported
physical activity level in the previous year was considered
as an ordinal variable and scored into five progressive
grades: 0 Z Sedentary or Light (<3 metabolic-equivalents,
METS) physical activity < 1 h/week; 1 Z Light physical
activity 2e4 h/week; 2 Z Light physical activity > 4 h/
week or Moderate (3e6 METS) physical activity 1e2 h/
week; 3 Z Moderate physical activity > 2 h/week;
4 Z Intense (>6 METS) physical activity several times
a week [30]. The pack-years index was calculated as
number of packs of cigarette smoked daily times years of
smoking. Total cholesterol, HDL-cholesterol and triglycer-
ides levels were determined by commercial assays (Roche
Diagnostics, Mannheim, Germany) and LDL-cholesterol
calculated using the Friedewald formula. Comorbid condi-
tions, such as hypertension, diabetes, metabolic syndrome,
peripheral artery disease, coronary artery disease and
chronic infections were ascertained according to pre-
established algorithms that combined information gath-
ered from medical history, medical records, clinical
examination, and blood and instrumental tests included in
the ‘‘InCHIANTI’’ Study protocol [26], and expressed as
categorical variables. With regard to hypertension, we
considered 140 mmHg and 90 mmHg as cut-off values for
systolic and diastolic blood pressure, respectively [31]. The
use of statins and/or antiinflammatory drugs was based
upon self-report.
Statistical analysis
Statistical analysis was performed using the STATA 7.0
software, from Stata Corporation (College Station, Texas,
USA) and carried out separately for three-year incidence
and prevalence of carotid artery plaques. The association
of participants’ baseline general characteristics,Please cite this article in press as: Molino-Lova R, et al., High sensit
artery plaques in older persons, Nutr Metab Cardiovasc Dis (2010), docardiovascular risk factors and inflammatory markers with
the three-year incidence (or prevalence) of carotid artery
plaques was first tested independent of the confounding
effect of age and sex. Then, variables showing significant
association with the three-year incidence (or prevalence)
of carotid artery plaques were entered into a logistic
regression-based model in which the three-year incidence
(or prevalence) of carotid artery plaques was considered as
the dependent variable. Continuous variables showing
a markedly skewed distribution, such as inflammatory
markers, were log-transformed before being entered into
calculations. Therefore, odds ratios in the models are
referred to as the difference of 1 unit in the log-
transformed value. Type 1 error was set at the two-sided
0.05 level.Results
The baseline prevalence of carotid artery plaques was 538
in 1168 participants (46%, 52% men and 41% women). Four
hundred twenty-six of the 538 participants (79%) showed
bilateral plaques, so that a total of 962 plaques were
detected. Of these, 78% were hyper-reflecting, 5% hypo-
reflecting and 17% mixed.
Table 1 (left side) shows baseline general characteris-
tics, cardiovascular risk factors and inflammatory markers
of InCHIANTI Study participants according to the presence
vs. absence of carotid artery plaques at baseline.
The baseline prevalence of carotid artery plaques was
significantly associated with older age, male gender, family
history of atherosclerosis, higher pack-years index, dia-
betes, hypertension, peripheral artery disease and higher
levels of CRP. When all these variables were entered into
a logistic regression-based model predicting presence vs.
absence of carotid artery plaques at baseline (Table 2, left
side) older age, male gender, higher pack-years index and
hypertension remained significantly associated with prev-
alent carotid artery plaques while family history of
atherosclerosis, diabetes, peripheral artery disease and
CRP were washed out.
The three-year incidence of carotid artery plaques was
195 in 486 participants (40%, 39% men and 41% women). One
hundred fifty-six of the 195 participants (80%) showed
bilateral plaques, so that a total of 351 plaques were
detected. Of these, 56% were hyper-reflecting, 32% hypo-
reflecting and 12% mixed.
Table 1 (right side) shows baseline general characteris-
tics, cardiovascular risk factors and inflammatory markers
of InCHIANTI Study participants according to the presence
vs. absence of new carotid artery plaques at three-year
follow-up among those participants without plaques at
baseline.
The three-year incidence of carotid artery plaques was
significantly associated with older age, family history of
atherosclerosis, higher pack-years index, coronary artery
disease and higher levels of CRP. When all these variables
were entered into a logistic regression-based model pre-
dicting presence vs. absence of new carotid artery plaques
at three-year follow-up in participants free from carotid
artery plaques at baseline (Table 2, right side), older age,
higher pack-years index, increased levels of CRP and familyivity C-reactive protein predicts the development of new carotid
i:10.1016/j.numecd.2010.02.003
Table 1 Baseline general characteristics, cardiovascular risk factors and inflammatory markers of InCHIANTI Study partici-
pants according to the presence vs. absence of carotid artery plaques at baseline (left side) and of new carotid artery plaques at
three-year follow-up (right side).
Carotid artery plaques at baseline
(n. 1168)a
New carotid artery plaques at follow-up
(n. 486)b
Presence Absence pc Presence Absence pc
n. 538 (46.1%) n. 630 n. 195 (40.1%) n. 291
General characteristics
Age (years) (mean  SD) 75.5  8.3 61.7  17.2 <0.001 71.2  7.2 56.6  16.9 < 0.001
Sex (% females) 49.6 60.0 <0.001 59.5 58.4 0.576
Chronic respiratory, urinary tract and
dental Infections (%)
49.7 33.4 0.316 43.7 24.7 0.260
Use of statins and/or antiinflammatory
drugs (%)
13.0 8.9 0.451 11.8 7.2 0.987
Cardiovascular risk factors
Family medical history of
atherosclerosis (%)
51.0 43.5 0.011 55.9 37.1 0.024
Physical activity level previous year
(score 0e4, 4 best) (mean  SD)
1.29  0.89 1.51  0.87 0.612 1.35  0.74 1.71  0.86 0.337
BMI (kg/m2) (mean  SD) 27.5  3.7 27.1  4.4 0.628 27.9  4.2 26.7  4.4 0.891
Pack-years Index (mean  SD) 15.1  22.1 7.6  14.4 <0.001 10.5  17.2 5.5  9.9 0.001
Total Cholesterol (mg/dL) (mean  SD) 219.2  39.4 212.6  40.1 0.173 221.1  36.3 210.1  41.6 0.637
LDL-Cholesterol (mg/dL) (mean  SD) 138.5  33.7 132.0  35.7 0.138 141.1  32.2 129.8  37.4 0.818
HDL-Cholesterol (mg/dL) (mean  SD) 54.5  15.1 56.0  14.4 0.687 54.2  12.5 56.9  14.8 0.269
Triglycerides (mg/dL) (mean  SD) 130.6  72.4 123.3  82.6 0.795 128.5  65.9 117.2  69.4 0.416
Diabetes (%) 13.5 6.3 0.021 9.7 2.6 0.104
Hypertension (%) 77.1 49.2 <0.001 62.2 36.0 0.780
Metabolic Syndrome (%) 25.6 18.5 0.135 20.8 16.4 0.280
Coronary artery disease (%) 9.5 3.2 0.080 6.6 0.3 0.037
Perpheral artery disease (%) 16.3 4.0 0.001 5.2 1.0 0.094
Inflammatory markers
C-reactive protein high sensitivity
(mg/mL) (mean  SD)d
5.89  10.81 3.76  6.56 0.006 4.45  5.30 2.57  3.56 0.005
Interleukin 1-b (pg/mL) (mean  SD)d 0.28  1.34 0.32  1.80 0.342 0.29  1.77 0.29  1.48 0.286
Interleukin 1 receptor antagonist
(pg/mL) (mean  SD)d
162.9  124.0 152.6  125.0 0.798 154.4  94.8 143.0  106.6 0.192
Interleukin 6 (pg/mL) (mean  SD)d 2.32  4.41 1.52  1.80 0.516 1.70  1.51 1.21  1.77 0.172
Interleukin 6 soluble receptor
(ng/mL) (mean  SD)d
105.0  55.6 99.3  58.6 0.148 102.7  59.7 99.5  61.7 0.341
Tumor necrosis factor a (pg/mL)
(mean  SD)d
3.85  6.00 3.02  3.92 0.891 3.22  4.14 2.69  3.55 0.672
Bold value indicates statistically significant p-values.
a Participants with complete data at baseline.
b Participants free from carotid artery plaques at baseline who received a carotid artery scan at three-year follow-up.
c From age- and sex-adjusted linear or logistic regressions, as appropriate.
d Variables log-transformed before being entered into regressions due to marked skewness.
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predictors of incident carotid artery plaques.
In a separate analysis, we also calculated relative risks,
along with their 95% confidence intervals (CI), for family
history of atherosclerosis and for categories of variables
previously reported as continuous variables. When
compared with participants aged less than 65 years, the
relative risk of developing new carotid artery plaques was
5.48 (95%CI: 5.02e5.94) for participants aged 65e69
years, 6.89 (95%CI: 6.44e7.35) for participants aged 70e
74 years, 8.04 (95%CI: 7.58e8.50) for participants agedPlease cite this article in press as: Molino-Lova R, et al., High sensit
artery plaques in older persons, Nutr Metab Cardiovasc Dis (2010), do75e79 years and 9.57 (95%CI: 9.12e10.02) for participants
aged 80 years or more. Heavy smokers (pack-years index
>20) had a relative risk of developing new plaques of 1.70
(95%CI: 1.48e1.93) when compared with subjects with no
or light smoking history (pack-years index 10). On the
contrary, moderate smoking (pack-year index, 11e20) was
not associated with differential risk. Participants who
reported family history of atherosclerosis had a relative
risk of developing new plaques of 1.57 (95%CI 1.35e1.79).
Finally, subjects with high (>3 mg/mL) or moderate (1
and 3 mg/mL) CRP levels had a relative risk of developingivity C-reactive protein predicts the development of new carotid
i:10.1016/j.numecd.2010.02.003
Table 2 Multivariate logistic regressions modeling the probability of having carotid artery plaques at baseline (left side) and
of developing new carotid artery plaques at three-year follow-up (right side).
Carotid artery
plaques at baseline (n 1168)
New carotid
artery plaques at follow-up (n 486)
LR chi2 Z 355.98; Prob > chi2 Z 0.0000;
Pseudo r2 Z 0.2352
LR chi2 Z 226.85; Prob > chi2 Z 0.0000;
Pseudo r2 Z 0.3468
OR (95%CI) p OR (95%CI) p
Age (years) 1.10 (1.08e1.12) <0.001 1.14 (1.10e1.18) <0.001
Female sex (Y/N) 0.62 (0.45e0.87) 0.005 a e
Family medical
history of atherosclerosis (Y/N)
1.12 (0.85e1.49) 0.416 1.79 (1.12e2.86) 0.015
Pack-years Index 1.02 (1.01e1.03) <0.001 1.03 (1.01e1.05) 0.002
Diabetes (Y/N) 1.54 (0.90e2.45) 0.093 a e
Hypertension (Y/N) 1.77 (1.30e2.42) <0.001 a e
Coronary artery disease (Y/N) a e 4.04 (0.49e33.10) 0.193
Peripheral artery disease (Y/N) 1.3 (0.87e1.94) 0.200 a e
C-reactive protein
high sensitivity (mg/mL)b
1.12 (0.97e1.28) 0.101 1.30 (1.08e1.64) 0.021
Bold value indicates statistically significant p-values.
a Variables not entered into the model due to the lack of association with the outcome after age- and sex-adjustment.
b Variables log-transformed before being entered into regressions due to marked skewness.
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1.91 (95%CI: 1.56e2.26), respectively, when compared
with subjects with low (<1 mg/mL) CRP levels.Discussion
Using data collected in a predominantly elderly population-
based cohort living in the Tuscany countryside we found
that older age, higher pack-years index, increased levels of
CRP and family history of atherosclerosis were strong
independent predictors of the development of new plaques
within three years among participants free from carotid
artery plaques.
The three-year incidence of carotid artery plaques was
40% (39% men and 41% women), corresponding to an
average incidence of 13% per year. To the best of our
knowledge, this is the first prospective study addressing
the issue of the development of new carotid artery pla-
ques in older persons. Therefore, our findings cannot be
directly compared with the existing literature. Indeed,
the 40% incidence of carotid artery plaques over 3 years
we found in our study might appear surprisingly high.
However, Johnsen et al. [32] also reported a 40% inci-
dence of carotid artery plaques. Though in the above
study the follow-up was longer (7 vs. 3 years), the
proportion of participants aged 65 years or older was
remarkably smaller than in our sample (25% vs. 72%).
Accordingly, the relevant presence of younger partici-
pants might have diluted the incidence of carotid artery
plaques among older persons.
Older age was a significant and independent predictor of
the development on new atherosclerotic plaques. This
finding confirms the established notion of the progressive
increase of cardiovascular risk with advancing age, that
reflects the cumulative nature of atherosclerosis [33]. The
lack of association between gender and three-yearPlease cite this article in press as: Molino-Lova R, et al., High sensit
artery plaques in older persons, Nutr Metab Cardiovasc Dis (2010), doincidence of carotid artery plaques is consistent with
previously reported data from the Rotterdam Study on the
progression of extra-coronary atherosclerosis in older
persons [7,34]. The development of new carotid artery
plaques was also significantly and independently associated
with the pack-years index, a measure of lifelong exposure
to smoking, and this is also consistent with the cumulative
nature of atherosclerosis [33].
Worthy of note, other cardiovascular risk factors, such
as hypertension, diabetes, dyslipidemia and overweight/
obesity, whose prevalence was moderately high in our
cohort (62.1%, 9.6%, 78.9% and 69.0% respectively), failed
to identify elderly subjects at risk of incident carotid artery
plaques.
Finally, increased levels of CRP and family history of
atherosclerosis independently predicted the prospective
development of new carotid artery plaques in older
persons. This finding is consistent with recently published
papers that have shown that by adding information on
inflammation, namely CRP, and genetic risk, namely family
history of cardiovascular events, the algorithms for the
assessment of global cardiovascular risk were considerably
improved both in women [2] and in men [3].
Interestingly, in spite of the predictive value of increased
levels of CRP on the development of new carotid artery
plaques, levels of several cytokines (CKs) were not associ-
ated with differential risk. This finding could be explained by
the lack of precision in CKs measurement methods or by the
wide short-term fluctuation in CKs circulating levels.
However, it may also be hypothesized that CRP might be
a summary measure of inflammation capturing the overall
burden more than the specific aspects of it, that are mostly
expressed by specific CKs. Alternatively, it may be hypoth-
esized that the moderately increased levels of CRP, as those
we found in participants that developed new carotid artery
plaques, result from local production. Accordingly, they
might reflect the early stage of the vessel inflammation thativity C-reactive protein predicts the development of new carotid
i:10.1016/j.numecd.2010.02.003
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[21,22]. Histological investigations have, in fact, shown that
CRP frequently co-localizes with the terminal complement
complex in the intima of early atherosclerotic lesions of
human coronary arteries [35], and that elongated muscle-
like cells positive for CRP can be found inside atheroscle-
rotic plaques [36]. Further, though the majority of CRP
commonly detected during the acute-phase response to
microbial infections, tissue injury or autoimmune disorders is
produced by the hepatocytes stimulated by increased levels
of IL-6 [37], recent papers have shown that small amounts of
CRP can also be produced by vascular smooth muscle cells
[38,39]. Noteworthy, CRP has been shown to be produced by
the vascular smooth muscle cells of atherosclerotic lesions
with active disease but not in end-stage plaques [36] and this
might also explain the lack of association of increased levels
of CRP with prevalent carotid artery plaques, 78% of which
showed a hyper-reflecting echographic pattern, usually
found in end-stage plaques.
Our study has limitations. In particular, as in all prospec-
tive studies that use a single baseline measurement to
predict future events, it is likely that random fluctuations of
risk factors over time led to a systematic underestimation of
the true association between risk factors and the develop-
ment of new carotid artery plaques [33]. Further, the lack of
intra-observer reliability assessment might also appear as
a potential limitation of this study. Actually, due to logistic
reasons, we were unable to obtain an appropriate set of
participants to be re-evaluated. In fact, to undergo carotid
artery scan, older participants had to move from home to the
ultrasound laboratory. However, the operator who per-
formed all carotid artery scans confirmed the presence of
carotid artery plaques in 347 over 353 (98%) participants with
carotid artery plaques at baseline who also underwent
carotid artery scan at follow-up. This might be considered an
indirect measure of the intra-observer reliability. Accord-
ingly, the lack of intra-observer reliability assessment should
not have significantly affected our results.
In conclusion, our findings provide the evidence that
increased levels of CRP predict the prospective develop-
ment of new plaques in older persons with carotid arteries
free from atherosclerotic lesions. Future studies are
needed to confirm our results on a broader scale and to
verify whether an aggressive medical treatment targeting
inflammatory pathways might also effectively prevent the
development of new plaques in older persons free from
carotid artery lesions and with increased levels of CRP.References
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